Will the Public Engage with New Pharmacy Roles? Assessing Future Uptake of a Community Pharmacy Health Check Using a Discrete Choice Experiment
Tóm tắt
Pharmacists are increasingly providing more clinically orientated services that focus on enhancing patient care and health promotion. However, little is known about how acceptable this is to the public. This study explored public preferences for a community pharmacy-based health check for cardiovascular disease (CVD). A convenience sample of 423 individuals was recruited (from a community pharmacy, a dental practice, a shopping centre, a university campus and a sports centre) to complete a discrete choice experiment (DCE) survey administered face to face on a tablet. The DCE included six attributes: day of the week (weekday or weekends); way of accessing the service (walk-in and wait or by appointment); provider of health check (trainee pharmacist, pharmacist or nurse); duration of health check (30 or 45 min); follow-up phone call (no, yes and within 3 months); and cost (included to estimate the monetary value of health checks). Experimental design methods were used to create 12 choice tasks describing different health check services. Mixed logit (MXL) was used to analyse response data. Respondents had a preference for a community pharmacy-based CVD health check over no health check. They preferred a service provided (i) at the weekend; (ii) by appointment; (iii) by a nurse; (iv) for 30 min and (v) with follow-up after 3 months. Respondents were willing to pay £50 for this health check. Findings affirm the public’s acceptance and value of a pharmacy-led CVD health check. The findings can inform pharmacy-based screening services before they are introduced, guide new service design and support resource allocation decisions.
Tài liệu tham khảo
Department of Health and Social Care. The community pharmacy contractual framework for 2019/20 to 2023/24: supporting delivery for the NHS long term plan; 2019. https://www.gov.uk/government/publications/community-pharmacy-contractual-framework-2019-to-2024. Accessed 22 Nov 2021.
Pharmacy and Medicine Division, Scottish Government. NHS Pharmacy First Scotland; 2020. https://www.cps.scot/featured/nhs-pharmacy-first-scotland. Accessed 22 Nov 2021.
Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. Res Soc Adm Pharm. 2020;16(9):1155–65. https://doi.org/10.1016/j.sapharm.2019.12.016.
Buss VH, Shield A, Kosari S, Naunton M. The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature. J Pharm Policy Pract. 2018;11(1):1–10. https://doi.org/10.1186/s40545-018-0149-7.
Porteous T, Ryan M, Bond C, Watson M, Watson V. Managing minor ailments; the public’s preferences for attributes of community pharmacies. A discrete choice experiment. PLoS ONE. 2016;11(3):e0152257. https://doi.org/10.1371/journal.pone.0152257.
Smith S, Porteous T, Bond C, et al. The help for hay fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis. Prim Care Respir Med. 2020. https://doi.org/10.1038/s41533-020-0180-4
Watson MC, Ferguson J, Barton GR, et al. A cohort study of influences, health outcomes and costs of patients’ health-seeking behaviour for minor ailments from primary and emergency care settings. BMJ Open. 2015;5:e006261. https://doi.org/10.1136/bmjopen-2014-006261.
Law MR, Ma T, Fisher J, Sketris IS. Independent pharmacist prescribing in Canada. Can Pharm J. 2012;145(1):17–23. https://doi.org/10.3821/1913-701X-145.1.17.
Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current practice and research. J Clin Pharm Ther. 2007;32(6):545–56. https://doi.org/10.1111/j.1365-2710.2007.00867.x.
Cox S, Dawkins L, Doshi J, Cameron J. Effects of e-cigarettes versus nicotine replacement therapy on short-term smoking abstinence when delivered at a community pharmacy. Addict Behav Rep. 2019;10:100202. https://doi.org/10.1016/j.abrep.2019.100202.
Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R, et al. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10:CD003698. https://doi.org/10.1002/14651858.CD003698.pub3.
Gauly J, Ross J, Hall I, Soda I, Atherton H. Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff. Sex Transm Infect. 2019;95(7):488–95. https://doi.org/10.1136/sextrans-2019-054096.
Gudka S, Afuwape FE, Wong B, Yow XL, Anderson C, Clifford RM. Chlamydia screening interventions from community pharmacies: a systematic review. Sex Health. 2013;10(3):229–39. https://doi.org/10.1071/SH12069.
Matheson C, Thiruvothiyur M, Robertson H, Bond C. Community pharmacy services for people with drug problems over two decades in Scotland: implications for future development. Int J Drug Policy. 2016;27:105–12. https://doi.org/10.1016/j.drugpo.2015.11.006.
Chaar BB, Hanrahan J, Day C. Provision of opioid substitution therapy services in Australian pharmacies. Australas Med J. 2011;4(4):210–6. https://doi.org/10.4066/AMJ.2011.706.
Inch J, Avenell A, Aucott L, Watson MC. A mixed-methods evaluation of a community pharmacy signposting service to a commercial weight-loss provider. Public Health Nutr. 2018;21(12):2311–9. https://doi.org/10.1017/S1368980018000733.
Morrison D, McLoone P, Brosnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health. 2013;13:282–90. https://doi.org/10.1186/1471-2458-13-282.
Gordon J, Watson M, Avenell A. Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obes Rev. 2011;12(11):897–911. https://doi.org/10.1111/j.1467-789X.2011.00913.x.
Pharmaceutical Services Negotiating Committee. Flu vaccination service. https://psnc.org.uk/services-commissioning/advanced-services/flu-vaccination-service/. Accessed 6 July 2021.
Pharmaceutical Services Negotiating Committee. COVID 19 vaccinations. https://psnc.org.uk/the-healthcare-landscape/covid19/covid-19-vaccinations/. Accessed 6 July 2021.
Jones JM, Kirkdale C, Thornley T. Travel health services provided through UK community pharmacies. Pharm J. 2017. https://pharmaceutical-journal.com/article/letters/travel-health-services-provided-through-uk-community-pharmacies. Accessed 6 July 2021.
Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45. https://doi.org/10.1093/eurheartj/ehw334.
Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182–9.
Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: a systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29–38. https://doi.org/10.1111/bcp.14164.
Department of Health. Economic modelling for vascular checks. https://webarchive.nationalarchives.gov.uk/20130123194328/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085869. Accessed 6 July 2021.
Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. Int J Pharm Pract. 2013;21(6):349–61. https://doi.org/10.1111/ijpp.12041.
Stokes G, Rees R, Khatwa M, et al. Public health service provision by community pharmacies: A systematic map of evidence. London: EPPI-Centre, Social Science Research Unit, Institute of Education, University College London; 2019.
General pharmaceutical services in England—2008/09–2018/19. https://www.digital.nhs.uk/data-and-information/publications/statistical/general-pharmaceutical-services/in-2008-09---2018-19-ns. Accessed 22 Nov 2021.
Taylor J, Krska J, MacKridge A. A community pharmacy-based cardiovascular screening service: views of service users and the public. Int J Pharm Pract. 2012;20(5):277–84. https://doi.org/10.1111/j.2042-7174.2012.00190.x.
Krska J, Taylor J, du Plessie R. Views and experiences of the NHS health check provided in pharmacies and medical practices. Int J Pharm Pract. 2013;21(Suppl 1):1–26. https://doi.org/10.1111/ijpp.12028_3.
De Bekker-Grob E, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21:145–72. https://doi.org/10.1002/hec.1697.
Naik-Panvelkar P, Armour C, Saini B. Discrete choice experiments in pharmacy. Int J Pharm Pract. 2013;21(1):3–19. https://doi.org/10.1111/ijpp.12002.
Glynn D. An investigation into the external invalidity of contingent valuation responses. Master dissertation, University of Aberdeen. 2013.
Office of Fair Trading. Evaluating the impact of the 2003 OFT study on the control of entry regulations in the retail pharmacies market. https://www.dotecon.com/assets/images/oft1219.pdf. Accessed 22 Nov 2021.
UK Department for Transport. National travel survey: 2012. https://www.gov.uk/government/statistics/national-travel-survey-2012. Accessed 22 Nov 2021.
Manski CF. The structure of random utility models. Theor Decis. 1977;8(3):229–54. https://doi.org/10.1007/bf00133443.
Hensher DA, Greene WH. The mixed logit model: the state of practice. Transportation. 2003;30(2):133–76. https://doi.org/10.1023/A:1022558715350.
Daly AJ, Hess S, Train KE. Assuring finite moments for willingness to pay in random coefficients models. Transportation. 2012;39(1):19–31. https://doi.org/10.1007/s11116-011-9331-3.
Train K. Discrete choice methods with simulation. 2nd ed. Cambridge: Cambridge University Press; 2009.
Anderson C, Thornley T. “It’s easier in pharmacy”: why some patients prefer to pay for flu jabs rather than use the national health service. BMC Health Serv Res. 2014;14:35–41. https://doi.org/10.1186/1472-6963-14-35.
Donyai P, Van Den Berg M. Coronary heart disease risk screening: the community pharmacy healthy heart assessment service. Pharm World Sci. 2009;31(6):643–7. https://doi.org/10.1007/s11096-009-9338-4.
Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of a cardiovascular disease opportunistic risk assessment pilot (‘heart MOT’ service) in community pharmacies. J Public Health (United Kingdom). 2010;32(1):110–6. https://doi.org/10.1093/pubmed/fdp092.
Corlett SA, Krska J. Evaluation of NHS health checks provided by community pharmacies. J Public Health. 2016;38(4):e516–23. https://doi.org/10.1093/pubmed/fdv153.
McNaughton RJ, Oswald NTA, Shucksmith JS, Heywood PJ, Watson PS. Making a success of providing NHS health checks in community pharmacies across the tees valley: a qualitative study. BMC Health Serv Res. 2011;11:222–9. https://doi.org/10.1186/1472-6963-11-222.
Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess. 2000;4(14):i–vii, 1–133.
Richards C. Vascular screening brings high hopes. Pharm J. 2009;282(7546):369–70.
Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. https://www.gov.uk/government/publications/evidence-review-criteria-national-screening-programmes/criteria-for-appraising-the-viability-effectiveness-and-appropriateness-of-a-screening-programme. Accessed 22 Nov 2021.
Boyd KA, Briggs AH. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction. 2009;104(2):317–25. https://doi.org/10.1111/j.1360-0443.2008.02449.x.
Anderson C, Sharma R. Primary health care policy and vision for community pharmacy and pharmacists in England. Pharm Pract (Granada). 2020;18(1):1870. https://doi.org/10.18549/PharmPract.2020.1.1870.
Johnson FR, Yang JC, Reed SD. The internal validity of discrete choice experiment data: a testing tool for quantitative assessments. Value Health. 2019;22(2):157–60. https://doi.org/10.1016/j.jval.2018.07.876.
Paudyal V, Cadogan C, Fialová D, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Social Adm Pharm. 2021;17(8):1507–17. https://doi.org/10.1016/j.sapharm.2020.11.017.